Compare
Quantum X Labs Inc. vs FiEE, Inc. vs Firefly Neuroscience, Inc. vs T Stamp Inc
| Latest fiscal year | Quantum X Labs Inc. QXL | FiEE, Inc. FIEE | Firefly Neuroscience, Inc. AIFF | T Stamp Inc IDAI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $6.19M | $1.14M | $3.14M |
| Revenue growth (YoY) | n/a | +867.9% | +957.4% | +1.9% |
| Gross margin | n/a | 86.4% | 56.5% | n/a |
| Operating margin | n/a | 25.0% | -775.5% | -244.0% |
| Net margin | n/a | 17.3% | n/m | -265.2% |
| Net income | -$19.29M | $1.07M | -$19.88M | -$8.33M |
| EPS (Diluted) | $2.28 | $0.10 | n/a | -$2.67 |
| Operating cash flow | -$2.77M | $3.64M | -$8.19M | -$5.69M |
| Free cash flow | n/a | $3.45M | n/a | -$5.73M |
| Cash & equivalents | $1.02M | $3.08M | n/a | $6.04M |
| Total assets | $10.76M | $10.77M | $10.48M | $11.24M |
| Total liabilities | n/a | $4.18M | $2.84M | $2.35M |
| Shareholders' equity | $4.99M | $6.59M | $7.64M | $8.89M |
| Return on year-end equity | -386.6% | 16.3% | -260.3% | -93.7% |
| Shares outstanding | 10.67M | 7.93M | 13.96M | 5.25M |
Revenue, most recent five fiscal years
| Fiscal year | Quantum X Labs Inc. | FiEE, Inc. | Firefly Neuroscience, Inc. | T Stamp Inc |
|---|---|---|---|---|
| Latest | $26.94M Ended 2024-12-31 | $6.19M Ended 2025-12-31 | $1.14M Ended 2025-12-31 | $3.14M Ended 2025-12-31 |
| 1 year earlier | $79.61M Ended 2023-12-31 | $639.9K Ended 2024-12-31 | $108.0K Ended 2024-12-31 | $3.08M Ended 2024-12-31 |
| 2 years earlier | $96.60M Ended 2022-12-31 | $26.11M Ended 2023-12-31 | $498.0K Ended 2023-12-31 | $4.56M Ended 2023-12-31 |
| 3 years earlier | $45.22M Ended 2021-12-31 | $50.62M Ended 2022-12-31 | $12.02M Ended 2022-12-31 | $5.39M Ended 2022-12-31 |
| 4 years earlier | $96.0K Ended 2020-12-31 | $55.42M Ended 2021-12-31 | $15.03M Ended 2021-12-31 | $3.68M Ended 2021-12-31 |